FDA allows marketing of cooling cap to reduce hair loss during chemotherapy
December 8, 2015 -- Today, the U.S. Food and Drug Administration cleared for marketing in the United States the first cooling cap to reduce hair loss (alopecia) in female breast cancer patients undergoing chemotherapy.
Hair loss is a common side...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Alopecia | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Food and Drug Administration (FDA) | Marketing | Pharmaceuticals